Objetivo Dado el creciente uso de las terapias biológicas en distintas enfermedades
reumatológicas, y la importancia de la gestión de riesgo de las mismas, desde la Sociedad …

Objetivo: Dado el creciente uso de las terapias biológicas en distintas enfermedades
reumatológicas, y la importancia de la gestión de riesgo de las mismas, desde la Sociedad …

Background Since the publication of the European League Against Rheumatism recommendations
for the pharmacological treatment of psoriatic arthritis (PsA) in 2012, new evidence …

Objective To update the European League Against Rheumatism (EULAR) recommendations
for the pharmacological treatment of psoriatic arthritis (PsA). Methods According to the …

Gut microbial dysbiosis is associated with the development of autoimmune disease, but the
mechanisms by which microbial dysbiosis affects the transition from asymptomatic …

Introduction The objective was to develop a questionnaire that can be used to calculate a
score reflecting the impact of psoriatic arthritis (PsA) from the patients’ perspective: the PsA …

At present only few biological data are available to indicate whether psoriatic arthritis (PsA)
is part of the spondyloarthropathy (SpA) concept, whether it is a separate disease entity or a …

Background Although targeted biological treatments have transformed the outlook for
patients with rheumatoid arthritis, 40% of patients show poor clinical response, which is …

Inflammatory diseases such as arthritis are chronic conditions that fail to resolve spontaneously.
While the cytokine and cellular pathways triggering arthritis are well defined, those …

Interleukin 17 (IL-17) is a proinflammatory cytokine that has been the focus of intensive
research because of its crucial role in the pathogenesis of different diseases across many …